VKTX - Viking Therapeutics, Inc.
32.98
1.470 4.457%
Share volume: 2,947,342
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$31.51
1.47
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 07-24-2024 | 10-23-2024 | 02-26-2025 | 04-24-2025 | 07-23-2025 | 10-22-2025 | 02-11-2026 | |
| Cash flow financing | 606.037 M | 2.905 M | 2.522 M | 1.000 M | 349.000 K | 507.000 K | 480.000 K | 75.103 M | |
| Other financing cash flows | 606.037 M | -4.386 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 73.948 M | |
| Cash flow | 140.111 M | -151.667 M | 6.461 M | -23.597 M | 11.263 M | -4.048 M | 66.502 M | 65.425 M | |
| Net income | -27.356 M | -22.250 M | -24.940 M | -35.417 M | -45.629 M | -65.561 M | -90.787 M | -157.662 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -459.792 M | -126.059 M | 25.901 M | 6.584 M | 63.245 M | 42.506 M | 160.025 M | 75.612 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 140.111 M | -151.667 M | 6.461 M | -23.597 M | 11.263 M | -4.048 M | 66.502 M | 65.425 M |